Market Cap 135.72M
Revenue (ttm) 0.00
Net Income (ttm) -95.49M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 868,700
Avg Vol 321,360
Day's Range N/A - N/A
Shares Out 65.88M
Stochastic %K 91%
Beta 0.36
Analysts Strong Sell
Price Target $9.50

Company Profile

IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating therapeutic cancer vaccines based on the T-win technology platform. The company's lead therapeutic cancer vaccine candidate includes IO102-IO103, which targets cancer cells and immune-suppressive cells in the tumor microenvironment that express indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 3 clinical trial to treat melanoma, as well as in phase 2 clinical trial to...

Industry: Biotechnology
Sector: Healthcare
Phone: 45 70 70 29 80
Address:
Ole MaalOees Vej 3, Copenhagen N, Copenhagen, Denmark
Casparov
Casparov Jul. 29 at 10:42 AM
$IOBT Mai-Britt Zocca (CEO): “We are actively building relationships with key opinion leaders and potential commercial partners to facilitate a smooth market introduction. The differentiation of Cylembio®, based on the unique T-cell targeting, is a strong point in discussions with payers and regulatory authorities.”
0 · Reply
Casparov
Casparov Jul. 29 at 10:41 AM
$IOBT Mai-Britt Zocca (CEO): “We expect the primary endpoint readout of our Phase III study with Cylembio® and pembrolizumab in Q3 this year. The interim data so far are encouraging and confirm our hypothesis that this combination significantly enhances the anti-tumor immune response. We are preparing for a smooth transition to regulatory filing once we have positive results.”
0 · Reply
MakeBux
MakeBux Jul. 29 at 9:48 AM
$IOBT is at a 2+ year high- a very bullish sign. $IOBT closed in the upper quadrant of yesterdays spike, also a very bullish sign. This is definitely one to watch.
0 · Reply
algo_alpha
algo_alpha Jul. 29 at 3:07 AM
Then: 📞 You called the floor. 📣 You didn’t wait — you acted. 🧠 Every trade carried weight because you had to own it. Now: 📱 You wait for green. 💬 You check what everyone else thinks. 🎯 It’s less about conviction, more about confirmation. 📉 You Wake Up as a Trader on Wall Street, 1986… When hesitation cost more than being wrong. https://www.youtube.com/watch?v=pRl2wYnIHTo $INTC $IOBT $IOVA $IREN $JASMY.X
1 · Reply
DrUpUpAway
DrUpUpAway Jul. 29 at 3:05 AM
$IOBT Lots of chatter now, retail mostly even with 2mil trading today, the bigger boys are still not come. I've shown the volume void in this zone, the warrants are here. Break out sustained to $3's+ would be nice but a new price floor here is also important. But be ready for the out of blue premarket data release and auto reprice. Negative $0.50 Positive $8-10? $14 ipo? $20?!! Mads amino sequences for the win!. iykyk ha!
1 · Reply
justiceforb_85
justiceforb_85 Jul. 29 at 2:49 AM
$IOBT continues to show strength. Even with the recent increase in stock price, this market cap is ridiculously low if their phase 3 trial is positive.
0 · Reply
algo_alpha
algo_alpha Jul. 29 at 1:57 AM
Then: 📞 No alerts. No notifications. 📣 You were the market scanner. Now: 📱 $INTC buzz on FinTwit. 🧠 $IOBT sentiment bots. 📊 You need five indicators to press “Buy.” 📉 You Wake Up as a Trader on Wall Street, 1986… No screen time. Just floor time. 🎧 https://www.youtube.com/watch?v=pRl2wYnIHTo $INTC $IOBT $IOVA $IREN $JASMY.X
0 · Reply
algo_alpha
algo_alpha Jul. 29 at 1:06 AM
Imagine shouting your order over a hundred other voices. No mouse. No charts. Just nerve. 📉 You Wake Up as a Trader on Wall Street, 1986… Built for market junkies. Dreamed for degens. 🎧 https://www.youtube.com/watch?v=pRl2wYnIHTo $IOBT $IOVA $IREN $LIDR $MCVT
0 · Reply
MakeBux
MakeBux Jul. 28 at 10:33 PM
$IOBT This stock has legs. It's been in an uptrend since November of last year, and now it's accelerating upwards. This was a big move today. I expect to see many more in the upcoming days/weeks.
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 28 at 8:08 PM
$IOBT Excellent article that nails exactly where IOBT stands right now. So if you want to update your IOBT knowledge or get acquainted with IOBT, this is a must read. https://beyondspx.com/article/io-biotech-a-high-stakes-bet-on-t-win-technology-ahead-of-pivotal-melanoma-data-iobt
0 · Reply
Latest News on IOBT
IO Biotech Reports 2024 Business Highlights

Mar 4, 2025, 4:17 PM EST - 5 months ago

IO Biotech Reports 2024 Business Highlights


IO Biotech: A Phase 3 Company Getting No Respect

Jan 3, 2024, 3:04 AM EST - 1 year ago

IO Biotech: A Phase 3 Company Getting No Respect


IO Biotech Announces 2023 Third Quarter Results

Nov 13, 2023, 8:12 AM EST - 1 year ago

IO Biotech Announces 2023 Third Quarter Results


IO Biotech Announces 2023 Second Quarter Results

Aug 11, 2023, 8:30 AM EDT - 2 years ago

IO Biotech Announces 2023 Second Quarter Results


IO Biotech Appoints Heidi Hunter to its Board of Directors

Aug 11, 2023, 8:05 AM EDT - 2 years ago

IO Biotech Appoints Heidi Hunter to its Board of Directors


IO Biotech to Present at the Jefferies Healthcare Conference

May 30, 2023, 4:35 PM EDT - 2 years ago

IO Biotech to Present at the Jefferies Healthcare Conference


IO Biotech Announces 2023 First-Quarter Results

May 11, 2023, 4:05 PM EDT - 2 years ago

IO Biotech Announces 2023 First-Quarter Results


IO Biotech Announces 2022 Fourth-Quarter and Year-End Results

Mar 14, 2023, 4:11 PM EDT - 2 years ago

IO Biotech Announces 2022 Fourth-Quarter and Year-End Results


Casparov
Casparov Jul. 29 at 10:42 AM
$IOBT Mai-Britt Zocca (CEO): “We are actively building relationships with key opinion leaders and potential commercial partners to facilitate a smooth market introduction. The differentiation of Cylembio®, based on the unique T-cell targeting, is a strong point in discussions with payers and regulatory authorities.”
0 · Reply
Casparov
Casparov Jul. 29 at 10:41 AM
$IOBT Mai-Britt Zocca (CEO): “We expect the primary endpoint readout of our Phase III study with Cylembio® and pembrolizumab in Q3 this year. The interim data so far are encouraging and confirm our hypothesis that this combination significantly enhances the anti-tumor immune response. We are preparing for a smooth transition to regulatory filing once we have positive results.”
0 · Reply
MakeBux
MakeBux Jul. 29 at 9:48 AM
$IOBT is at a 2+ year high- a very bullish sign. $IOBT closed in the upper quadrant of yesterdays spike, also a very bullish sign. This is definitely one to watch.
0 · Reply
algo_alpha
algo_alpha Jul. 29 at 3:07 AM
Then: 📞 You called the floor. 📣 You didn’t wait — you acted. 🧠 Every trade carried weight because you had to own it. Now: 📱 You wait for green. 💬 You check what everyone else thinks. 🎯 It’s less about conviction, more about confirmation. 📉 You Wake Up as a Trader on Wall Street, 1986… When hesitation cost more than being wrong. https://www.youtube.com/watch?v=pRl2wYnIHTo $INTC $IOBT $IOVA $IREN $JASMY.X
1 · Reply
DrUpUpAway
DrUpUpAway Jul. 29 at 3:05 AM
$IOBT Lots of chatter now, retail mostly even with 2mil trading today, the bigger boys are still not come. I've shown the volume void in this zone, the warrants are here. Break out sustained to $3's+ would be nice but a new price floor here is also important. But be ready for the out of blue premarket data release and auto reprice. Negative $0.50 Positive $8-10? $14 ipo? $20?!! Mads amino sequences for the win!. iykyk ha!
1 · Reply
justiceforb_85
justiceforb_85 Jul. 29 at 2:49 AM
$IOBT continues to show strength. Even with the recent increase in stock price, this market cap is ridiculously low if their phase 3 trial is positive.
0 · Reply
algo_alpha
algo_alpha Jul. 29 at 1:57 AM
Then: 📞 No alerts. No notifications. 📣 You were the market scanner. Now: 📱 $INTC buzz on FinTwit. 🧠 $IOBT sentiment bots. 📊 You need five indicators to press “Buy.” 📉 You Wake Up as a Trader on Wall Street, 1986… No screen time. Just floor time. 🎧 https://www.youtube.com/watch?v=pRl2wYnIHTo $INTC $IOBT $IOVA $IREN $JASMY.X
0 · Reply
algo_alpha
algo_alpha Jul. 29 at 1:06 AM
Imagine shouting your order over a hundred other voices. No mouse. No charts. Just nerve. 📉 You Wake Up as a Trader on Wall Street, 1986… Built for market junkies. Dreamed for degens. 🎧 https://www.youtube.com/watch?v=pRl2wYnIHTo $IOBT $IOVA $IREN $LIDR $MCVT
0 · Reply
MakeBux
MakeBux Jul. 28 at 10:33 PM
$IOBT This stock has legs. It's been in an uptrend since November of last year, and now it's accelerating upwards. This was a big move today. I expect to see many more in the upcoming days/weeks.
0 · Reply
NVDAMillionaire
NVDAMillionaire Jul. 28 at 8:08 PM
$IOBT Excellent article that nails exactly where IOBT stands right now. So if you want to update your IOBT knowledge or get acquainted with IOBT, this is a must read. https://beyondspx.com/article/io-biotech-a-high-stakes-bet-on-t-win-technology-ahead-of-pivotal-melanoma-data-iobt
0 · Reply
Doozio
Doozio Jul. 28 at 7:20 PM
$IOBT maybe let’s scrabble bag it $RBOT wen all da furu 🐑 been SPOT. 🐒🍌🧠⏰♾️
1 · Reply
badprecog
badprecog Jul. 28 at 6:17 PM
$IOBT n=17 is small but in CheckMate-067 PD-L1+ ORR came in at 58.9%. Seems like a lock for best in class but seems like a ring the bell before the fight begins for PD-L1+!
0 · Reply
Will_Birkin
Will_Birkin Jul. 28 at 6:14 PM
$IOBT BO when
0 · Reply
kshonstocks
kshonstocks Jul. 28 at 6:08 PM
$IOBT higher highs and days hi
0 · Reply
badprecog
badprecog Jul. 28 at 5:42 PM
$IOBT Looks like it's about to go loco?
1 · Reply
Rockymntn888
Rockymntn888 Jul. 28 at 5:40 PM
0 · Reply
Rockymntn888
Rockymntn888 Jul. 28 at 5:36 PM
$HCTI $IOBT starting to run, its the next great opportunity
1 · Reply
Rockymntn888
Rockymntn888 Jul. 28 at 5:24 PM
$IOBT a little buying pressure and this thing is going to moon!!!
0 · Reply
Rockymntn888
Rockymntn888 Jul. 28 at 5:09 PM
$HCTI $IOBT both starting to run. Get in while you can 🚀
0 · Reply
IanMaui
IanMaui Jul. 28 at 4:56 PM
$IOBT Getting close...
1 · Reply
badprecog
badprecog Jul. 28 at 4:55 PM
$IOBT Cat is getting out of the bag a bit more looks like.
0 · Reply
Bazzil
Bazzil Jul. 28 at 4:49 PM
$IOBT cue up the "somebody knows something" posts 😅
0 · Reply